Back

Improved diastolic stiffness through restored endothelial function and titin phosphorylation with chronic stimulation of soluble guanylyl cyclase in heart failure with preserved ejection fraction

28 May 2018 (10:12 - 10:18)
Organised by:
Congress Presentation Part of: Moderated Poster session 4 - Basic Science Heart Failure with Preserved Ejection Fraction (HFpEF) HFA Premium Access Heart Failure 2018

About the speaker

Photo
Doctor Arpad Kovacs

University of Debrecen, Debrecen (Hungary)

9 More presentations in this session

Presentation thumbnail
Alpha1-adrenergic receptor agonists activate Akt signalling via insulin family receptors
Doctor D. Meijles (London, GB)
Abstract
Presentation thumbnail
Kruppel-like factors regulation in a zebrafish heart failure model
Mr A. Lumley (Luxembourg, LU)
Abstract
Presentation thumbnail
A comparative study of LCZ696, valsartan and resveratrol for the treatment of acute cardiac remodeling and dysfunction in myocardial infarction induced rats
Mr P. Raj (Manitoba, CA)
Abstract
Presentation thumbnail
Omecamtive mecarbil causes alternating excitation-contraction coupling at high pacing frequencies
Doctor B. Horvath (Debrecen, HU)
Abstract
Presentation thumbnail
Colchicine improves experimental murine Coxsackievirus B3-induced myocarditis involving the NLRP3 inflammasome
Doctor S. Van Linthout (Berlin, DE)
Abstract

Access the full session

Session thumbnail
Moderated Poster session 4 - Basic Science

The Event

Event poster

Heart Failure 2018

28 May 2018 10:12 CET
You may be interested in
thumbnail
Congress Presentation
A soluble guanylate cyclase stimulator improves survival in a rat model of heart failure with reduced ejection fraction and chronic kidney disease induced by aorto-caval fistula and 5/6 nephrectomy
1 September 2025
thumbnail
Congress Presentation
Haemodynamic and cardiac mechanical adaptations following isometric exercise training in patients with heart failure with preserved ejection fraction.
13 December 2024
thumbnail
Congress Session
From genetic signatures to clinical implications
18 May 2025
thumbnail
Congress Presentation
Assessment of cardiac reverse remodeling in patients with LV systolic dysfunction receiving vericiguat in addition to optimal GDMT
13 December 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources